INDRAPRASTHA MEDICAL Fact Sheet, INDRAPRASTHA MEDICAL Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Fact Sheet    (IRMED)


REVEALED: Details of 3 "Super Smallcap" Stocks Nobody Tells You About...


Here is the latest financial fact sheet of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL quarterly results and INDRAPRASTHA MEDICAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

INDRAPRASTHA MEDICAL Price History

Price Rs 78.7
Mkt Cap Rs m 7,210
Vol '000 19.9
P/E X 16.8
P/CF X 9.4
EPS (TTM) Rs 4.7
% ch % -1.6
No. of shares m 91.67
% ch week % -0.1
% ch 1-mth % -4.2
% ch 12-mth % 63.0
52 week H/L Rs 102.6/45.3
(As on Sep 17, 2021 12:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDRAPRASTHA MEDICAL Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
INDRAPRASTHA MEDICAL EQUITY SHARE DATA
High Rs7763685252 
Low Rs4645453627 
Sales per share (Unadj.) Rs82.483.581.686.090.6 
Earnings per share (Unadj.) Rs2.72.92.33.14.8 
Diluted earnings per shareRs2.72.92.33.14.8 
Cash flow per share (Unadj.) Rs6.56.25.66.38.4 
Dividends per share (Unadj.) Rs1.801.801.501.600 
Adj. dividends per shareRs1.801.801.501.600.00 
Avg Dividend yield %2.93.32.63.60 
Book value per share (Unadj.) Rs24.425.225.326.629.2 
Adj. book value per shareRs24.425.225.326.629.2 
Shares outstanding (eoy) m91.6791.6791.6791.6791.67 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.70.60.70.50.4 
Avg P/E ratio x23.118.924.714.28.4 
P/CF ratio (eoy) x9.48.810.16.94.8 
Price / Book Value ratio x2.52.22.21.71.4 
Dividend payout %67.562.965.251.60 
Avg Mkt Cap Rs m5,6474,9695,2124,0403,660 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,8161,9031,9402,0022,139 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
INDRAPRASTHA MEDICAL INCOME DATA
Net Sales Rs m7,5547,6577,4847,8828,308 
Other income Rs m2151657 
Total revenues Rs m7,5767,6627,5007,8868,315 
Gross profit Rs m794788720808864 
Depreciation Rs m353305307298330 
Interest Rs m7479896959 
Profit before tax Rs m387408340446482 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m14314612916246 
Profit after tax Rs m244262211284436 
Gross profit margin %10.510.39.610.210.4 
Effective tax rate %36.935.737.936.39.5 
Net profit margin %3.23.42.83.65.3 
INDRAPRASTHA MEDICAL BALANCE SHEET DATA
Current assets Rs m1,5221,5791,3611,3561,415 
Current liabilities Rs m1,9051,8571,4161,2411,396 
Net working cap to sales %-5.1-3.6-0.71.50.2 
Current ratio x0.80.91.01.11.0 
Inventory Days Days22332 
Debtors Days Days4147433535 
Net fixed assets Rs m3,0833,0053,0012,8683,075 
Share capital Rs m917917917917917 
"Free" reserves Rs m1,3211,3921,4061,5241,761 
Net worth Rs m2,2372,3082,3232,4402,678 
Long term debt Rs m2502101500 
Total assets Rs m4,6054,5844,3624,2244,490 
Interest coverage x6.26.24.87.59.1 
Debt to equity ratio x000.10.10 
Sales to assets ratio x1.61.71.71.91.9 
Return on assets %6.97.46.98.411.0 
Return on equity %10.911.49.111.616.3 
Return on capital %20.421.116.919.920.2 
Exports to sales %00000 
Imports to sales %0.30.10.200 
Exports (fob) Rs m00000 
Imports (cif) Rs m2161600 
Fx inflow Rs m1,0411,2581,5581,4831,408 
Fx outflow Rs m262197255149344 
Net fx Rs m7791,0611,3031,3341,064 
INDRAPRASTHA MEDICAL CASH FLOW
From Operations Rs m 623 276 477 752 865 
From Investments Rs m -327 -224 -299 -167 -402 
From Financial Activity Rs m -300 -54 -172 -442 -427 
Net Cashflow Rs m -5 -2 6 143 35 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.0%
Institution 0.0%
Non-Institution 49.0%
Total 100.0%
Free Float 49.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Sarita Vihar, Delhi - Mathura Road, New Delhi - 110076
E-MAIL asinghal@apollohospitals.com. WEB www.apollohospdelhi.com
TEL 011- 26925858 26925801 FAX 011- 26825601
SECTOR HOSPITAL & HEALTHCARE SERVICES GROUP Apollo Hospitals Group
TR AGENT Link Intime India Pvt Ltd., Noble Heights 1st Floor Plot NH 2, C-1 Block LSC Near Savitri Market, Janakpuri
AUDITOR S. C. Vasudeva & Co.
CHM: S. K. Srivastava COMP SEC: A. K. Singhal YEAR OF INC: 1988 BSE CODE: 532150 FV (Rs): 10 DIV YIELD (%): -

Read: INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis

More Hospital & Healthcare Services Company Fact Sheets:   SHALBY   PFIZER  KERALA AYURV  THEMIS MEDICARE  PARMAX PHARMA  

Compare INDRAPRASTHA MEDICAL With:   SHALBY   PFIZER  KERALA AYURV  THEMIS MEDICARE  PARMAX PHARMA  




Today's Market

Sensex Jumps 400 Points to Hit Fresh Record High; Bajaj Finance & ITC Top Gainers(09:30 am)

Asian stock markets are trading on a steady note today as traders weighed risks from China to the global recovery and the prospect of reduced Federal Reserve stimulus.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit (Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - DR.AGAR.EYE COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS